Results 11 to 20 of about 92,889 (88)
C-258 SE ALISTA PLANETARIO DEL IPN PARA LA NOCHE DE LAS ESTRELLAS 2014
C-258 SE ALISTA PLANETARIO DEL IPN PARA LA NOCHE DE LAS ESTRELLAS 2014C-258 SE ALISTA PLANETARIO DEL IPN PARA LA NOCHE DE LAS ESTRELLAS ...
Coordinación de Comunicación Social, Imágenes
core +21 more sources
CIGB-258, péptido inhibidor de la hiperinflamación en pacientes con COVID-19
Introducción. El CIGB-258 es un péptido, cuyo mecanismo de acción se ha asociado con la inhibición de la inflamación. El presente trabajo tiene como objetivo demostrar que el CIGB-258 reduce la hiperinflamación en los pacientes con COVID-19. Métodos.
María del Carmen Domínguez Horta +12 more
doaj +1 more source
Péptido inmumodulador CIGB-258 para el tratamiento de pacientes graves y críticos con la COVID-19
Introducción: El CIGB-258 es un péptido inmunomodulador con propiedades antiinflamatorias. Objetivos: Establecer la frecuencia de dosis y el tiempo de tratamiento con el péptido CIGB-258, para pacientes críticos con la COVID-19. Además, definir los criterios de uso y el esquema terapéutico del péptido, para pacientes graves con la COVID-19. Métodos: Se
Rafael Venegas Rodríguez +14 more
openaire +3 more sources
CIGB-258 immunomodulatory peptide: a novel promising treatment for critical and severe COVID-19 patients [PDF]
Abstract This study characterizes the first clinical application of CIGB-258 in COVID-19 patients. CIGB-258 is an immunoregulatory peptide, derived from the cellular heat shock protein 60 (HSP60). Sixteen patients with COVID-19 in serious (31%) or critical (69%) conditions were included in this study.
Venegas-Rodriguez, R +14 more
openaire +1 more source
Hepatic encephalopathy is a complex life-threatening neuropsychiatric syndrome, which can be associated with acute inflammation. It can be found in cases of acute liver failure caused by a viral infection. Reports of patients infected with SARS-CoV-2 have described hepatic encephalopathy.
M González-Zorrilla +11 more
openaire +2 more sources
Introduction: Infection with SARS-CoV-2 induces a prothrombotic state in patients, by the combination of hyperinflammatory response and hypoxia. In Cuba, the drug called Jusvinza, based on an immunomodulatory peptide, is used for the treatment of ...
Rafael Venegas Rodríguez +13 more
doaj +2 more sources
Comparative analysis reveals amino acids critical for anticancer activity of peptide CIGB-552 [PDF]
Because of resistance development by cancer cells against current anticancer drugs, there is a considerable interest in developing novel antitumor agents.
Bollati Fogolín, Mariela +10 more
core +1 more source
The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1
CIGB-552 is a synthetic anti-tumor peptide capable of reducing tumor size and increasing the lifespan of tumor-bearing mice. Part of its anti-cancer effects consists of inducing apoptosis, modulating NF-kB signaling pathway, and the angiogenesis process.
Maribel Guerra Vallespí +4 more
core +1 more source
Encefalopatía como forma de presentación de la COVID-19
Introducción: El virus SARS-CoV-2, responsable de la COVID-19 presenta una alta tasa de contagio y es capaz de producir afecciones a diferentes niveles en el organismo, e incluye el sistema nervioso central, con manifestaciones como crisis convulsiva ...
Jorge Félix Nuñez Martínez +4 more
doaj
Abstract 6232: Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization [PDF]
CK2 is a serine/threonine kinase that is overexpressed in breast cancer and its inhibition is associated to reduced tumor growth and disease progression.
Perera, Yasser +14 more
core +1 more source

